Multi-institutional Survey of Laparoscopic Ureterolysis for Retroperitoneal Fibrosis

David A. Duchene, Howard N. Winfield, Jeffrey A Cadeddu, Ralph V. Clayman, Leonard G. Gomella, Louis R. Kavoussi, Albert A. Mikhail, Sangtae Park, Sompol Permpongkosol, Arieh L. Shalhav

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Objectives: Medical therapy often fails to cure benign retroperitoneal fibrosis (RPF), necessitating a surgical approach. Preoperative and postoperative adjuvant medical therapy and the timing of surgical intervention are not well-established. We surveyed centers of laparoscopic excellence to determine the current practices in the treatment of RPF. Methods: Surveys were sent to all institutions with Endourological Society-recognized fellowships. The data collected were analyzed for trends in the treatment of RPF. Additional information was collected from participating institutions to better characterize the experience with laparoscopic ureterolysis and adjunctive medical management. Results: Of the surveys sent out, 17 completed surveys were returned (41%). A total of 73 patients had been treated for RPF. Most centers (13 of 17) used a conventional laparoscopic approach with rare conversion to hand assistance. The medical management of RPF was directed by urologists, rheumatologists, or other specialists in 59%, 24%, and 18% of institutions, respectively. Steroid therapy was administered preoperatively by 15 of 17 centers. Postoperatively, 10 of 17 centers continued treatment with steroids and/or cytotoxic agents. Eight institutions provided data on 46 renal units in the second part of the study. The success rate of laparoscopic ureterolysis per renal unit was 83% (38 of 46). No difference was seen in the outcomes of patients who received adjuvant medical therapy compared with those who did not (16 of 19 versus 22 of 27; P = 0.48) after a mean follow-up of 17.7 months. Conclusions: The results of this study have shown that no uniform treatment algorithm exists for RPF at centers of laparoscopic excellence. Most institutions recommended an attempt at steroids followed by laparoscopic ureterolysis. Laparoscopic ureterolysis had a high success rate, and adjuvant medical therapy did not appear to contribute to the success rate.

Original languageEnglish (US)
Pages (from-to)1017-1021
Number of pages5
JournalUrology
Volume69
Issue number6
DOIs
StatePublished - Jun 2007

Fingerprint

Retroperitoneal Fibrosis
Therapeutics
Steroids
Kidney
Surveys and Questionnaires
Cytotoxins
Hand

ASJC Scopus subject areas

  • Urology

Cite this

Duchene, D. A., Winfield, H. N., Cadeddu, J. A., Clayman, R. V., Gomella, L. G., Kavoussi, L. R., ... Shalhav, A. L. (2007). Multi-institutional Survey of Laparoscopic Ureterolysis for Retroperitoneal Fibrosis. Urology, 69(6), 1017-1021. https://doi.org/10.1016/j.urology.2007.02.004

Multi-institutional Survey of Laparoscopic Ureterolysis for Retroperitoneal Fibrosis. / Duchene, David A.; Winfield, Howard N.; Cadeddu, Jeffrey A; Clayman, Ralph V.; Gomella, Leonard G.; Kavoussi, Louis R.; Mikhail, Albert A.; Park, Sangtae; Permpongkosol, Sompol; Shalhav, Arieh L.

In: Urology, Vol. 69, No. 6, 06.2007, p. 1017-1021.

Research output: Contribution to journalArticle

Duchene, DA, Winfield, HN, Cadeddu, JA, Clayman, RV, Gomella, LG, Kavoussi, LR, Mikhail, AA, Park, S, Permpongkosol, S & Shalhav, AL 2007, 'Multi-institutional Survey of Laparoscopic Ureterolysis for Retroperitoneal Fibrosis', Urology, vol. 69, no. 6, pp. 1017-1021. https://doi.org/10.1016/j.urology.2007.02.004
Duchene, David A. ; Winfield, Howard N. ; Cadeddu, Jeffrey A ; Clayman, Ralph V. ; Gomella, Leonard G. ; Kavoussi, Louis R. ; Mikhail, Albert A. ; Park, Sangtae ; Permpongkosol, Sompol ; Shalhav, Arieh L. / Multi-institutional Survey of Laparoscopic Ureterolysis for Retroperitoneal Fibrosis. In: Urology. 2007 ; Vol. 69, No. 6. pp. 1017-1021.
@article{c1a3418f41d242bdbb4d4653199fec72,
title = "Multi-institutional Survey of Laparoscopic Ureterolysis for Retroperitoneal Fibrosis",
abstract = "Objectives: Medical therapy often fails to cure benign retroperitoneal fibrosis (RPF), necessitating a surgical approach. Preoperative and postoperative adjuvant medical therapy and the timing of surgical intervention are not well-established. We surveyed centers of laparoscopic excellence to determine the current practices in the treatment of RPF. Methods: Surveys were sent to all institutions with Endourological Society-recognized fellowships. The data collected were analyzed for trends in the treatment of RPF. Additional information was collected from participating institutions to better characterize the experience with laparoscopic ureterolysis and adjunctive medical management. Results: Of the surveys sent out, 17 completed surveys were returned (41{\%}). A total of 73 patients had been treated for RPF. Most centers (13 of 17) used a conventional laparoscopic approach with rare conversion to hand assistance. The medical management of RPF was directed by urologists, rheumatologists, or other specialists in 59{\%}, 24{\%}, and 18{\%} of institutions, respectively. Steroid therapy was administered preoperatively by 15 of 17 centers. Postoperatively, 10 of 17 centers continued treatment with steroids and/or cytotoxic agents. Eight institutions provided data on 46 renal units in the second part of the study. The success rate of laparoscopic ureterolysis per renal unit was 83{\%} (38 of 46). No difference was seen in the outcomes of patients who received adjuvant medical therapy compared with those who did not (16 of 19 versus 22 of 27; P = 0.48) after a mean follow-up of 17.7 months. Conclusions: The results of this study have shown that no uniform treatment algorithm exists for RPF at centers of laparoscopic excellence. Most institutions recommended an attempt at steroids followed by laparoscopic ureterolysis. Laparoscopic ureterolysis had a high success rate, and adjuvant medical therapy did not appear to contribute to the success rate.",
author = "Duchene, {David A.} and Winfield, {Howard N.} and Cadeddu, {Jeffrey A} and Clayman, {Ralph V.} and Gomella, {Leonard G.} and Kavoussi, {Louis R.} and Mikhail, {Albert A.} and Sangtae Park and Sompol Permpongkosol and Shalhav, {Arieh L.}",
year = "2007",
month = "6",
doi = "10.1016/j.urology.2007.02.004",
language = "English (US)",
volume = "69",
pages = "1017--1021",
journal = "Urology",
issn = "0090-4295",
publisher = "Elsevier Inc.",
number = "6",

}

TY - JOUR

T1 - Multi-institutional Survey of Laparoscopic Ureterolysis for Retroperitoneal Fibrosis

AU - Duchene, David A.

AU - Winfield, Howard N.

AU - Cadeddu, Jeffrey A

AU - Clayman, Ralph V.

AU - Gomella, Leonard G.

AU - Kavoussi, Louis R.

AU - Mikhail, Albert A.

AU - Park, Sangtae

AU - Permpongkosol, Sompol

AU - Shalhav, Arieh L.

PY - 2007/6

Y1 - 2007/6

N2 - Objectives: Medical therapy often fails to cure benign retroperitoneal fibrosis (RPF), necessitating a surgical approach. Preoperative and postoperative adjuvant medical therapy and the timing of surgical intervention are not well-established. We surveyed centers of laparoscopic excellence to determine the current practices in the treatment of RPF. Methods: Surveys were sent to all institutions with Endourological Society-recognized fellowships. The data collected were analyzed for trends in the treatment of RPF. Additional information was collected from participating institutions to better characterize the experience with laparoscopic ureterolysis and adjunctive medical management. Results: Of the surveys sent out, 17 completed surveys were returned (41%). A total of 73 patients had been treated for RPF. Most centers (13 of 17) used a conventional laparoscopic approach with rare conversion to hand assistance. The medical management of RPF was directed by urologists, rheumatologists, or other specialists in 59%, 24%, and 18% of institutions, respectively. Steroid therapy was administered preoperatively by 15 of 17 centers. Postoperatively, 10 of 17 centers continued treatment with steroids and/or cytotoxic agents. Eight institutions provided data on 46 renal units in the second part of the study. The success rate of laparoscopic ureterolysis per renal unit was 83% (38 of 46). No difference was seen in the outcomes of patients who received adjuvant medical therapy compared with those who did not (16 of 19 versus 22 of 27; P = 0.48) after a mean follow-up of 17.7 months. Conclusions: The results of this study have shown that no uniform treatment algorithm exists for RPF at centers of laparoscopic excellence. Most institutions recommended an attempt at steroids followed by laparoscopic ureterolysis. Laparoscopic ureterolysis had a high success rate, and adjuvant medical therapy did not appear to contribute to the success rate.

AB - Objectives: Medical therapy often fails to cure benign retroperitoneal fibrosis (RPF), necessitating a surgical approach. Preoperative and postoperative adjuvant medical therapy and the timing of surgical intervention are not well-established. We surveyed centers of laparoscopic excellence to determine the current practices in the treatment of RPF. Methods: Surveys were sent to all institutions with Endourological Society-recognized fellowships. The data collected were analyzed for trends in the treatment of RPF. Additional information was collected from participating institutions to better characterize the experience with laparoscopic ureterolysis and adjunctive medical management. Results: Of the surveys sent out, 17 completed surveys were returned (41%). A total of 73 patients had been treated for RPF. Most centers (13 of 17) used a conventional laparoscopic approach with rare conversion to hand assistance. The medical management of RPF was directed by urologists, rheumatologists, or other specialists in 59%, 24%, and 18% of institutions, respectively. Steroid therapy was administered preoperatively by 15 of 17 centers. Postoperatively, 10 of 17 centers continued treatment with steroids and/or cytotoxic agents. Eight institutions provided data on 46 renal units in the second part of the study. The success rate of laparoscopic ureterolysis per renal unit was 83% (38 of 46). No difference was seen in the outcomes of patients who received adjuvant medical therapy compared with those who did not (16 of 19 versus 22 of 27; P = 0.48) after a mean follow-up of 17.7 months. Conclusions: The results of this study have shown that no uniform treatment algorithm exists for RPF at centers of laparoscopic excellence. Most institutions recommended an attempt at steroids followed by laparoscopic ureterolysis. Laparoscopic ureterolysis had a high success rate, and adjuvant medical therapy did not appear to contribute to the success rate.

UR - http://www.scopus.com/inward/record.url?scp=34249987670&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34249987670&partnerID=8YFLogxK

U2 - 10.1016/j.urology.2007.02.004

DO - 10.1016/j.urology.2007.02.004

M3 - Article

C2 - 17572177

AN - SCOPUS:34249987670

VL - 69

SP - 1017

EP - 1021

JO - Urology

JF - Urology

SN - 0090-4295

IS - 6

ER -